Position in ADMA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$20,577,128
-$21,391,379 QoQ
Shares Held
2,283,810
-0.7% QoQ
Ownership
0.985%
of shares outstanding
% of Portfolio
1.50%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 90.14388237200117.ToString("F0")%
Shared 0.ToString("F0")%
None 9.856117627998827.ToString("F0")%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ranger Investment Management, L.P. holds $74,071,947 across 2 Biotechnology names. ADMA ranks #2 (27.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
267,943 | $53,494,819 | |
| 2 | ADMA |
Adma Biologics, Inc.
This page
|
2,283,810 | $20,577,128 |
All Filings in ADMA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,577,128 | 2,283,810 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $41,968,507 | 2,300,905 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $34,315,101 | 2,340,730 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $43,528,728 | 2,390,375 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $31,813,638 | 1,603,510 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||